Adipose tissue remodeling: Its role in energy metabolism and metabolic disorders

Frontiers in Endocrinology

Volumn 7, Issue APR, 2016, Pages

  Choe, Sung Sik ^a   Huh, Jin Young ^a   Hwang, In Jae ^a   Kim, Jong In ^a   Kim, Jae Bum ^a  

^a Seoul National University   (South Korea)

Author keywords

Adipose tissue; Adipose tissue macrophage; Hypertrophic adipocyte; Inflammatory response; INKT cell; Metabolic disorder; Obesity

Indexed keywords

ADIPOCYTOKINE; CCAAT ENHANCER BINDING PROTEIN; CYTOKINE; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCOUPLING PROTEIN 1; VASCULOTROPIN;

ADIPOCYTE; ADIPOSE TISSUE; ADRENERGIC TRANSMISSION; ANGIOGENESIS; BROWN ADIPOSE TISSUE; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; HYPERPLASIA; HYPERTROPHY; HYPOTHALAMUS; HYPOXIA; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE; METABOLIC DISORDER; NONHUMAN; REVIEW; THERMOGENESIS; THERMOREGULATION; WHITE ADIPOSE TISSUE;

EID: 84964901761     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00030     Document Type: Review

References (198)

1. Birsoy K, Festuccia WT, Laplante M. A comparative perspective on lipid storage in animals. J Cell Sci (2013) 126:1541-52. doi:10.1242/jcs.104992
2. Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 11:738-49. doi:10.1038/nri3071
3. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm (2013) 2013:139239. doi:10.1155/2013/139239
4. Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells (2014) 37:365-71. doi:10.14348/molcells.2014.0074
5. McKay RM, McKay JP, Avery L, GraffJM. C. elegans: a model for exploring the genetics of fat storage. Dev Cell (2003) 4:131-42. doi:10.1016/S1534-5807(02)00411-2
6. Van Vleet ES, Candileri S, McNeillie J, Reinhardt SB, Conkright ME, Zwissler A. Neutral lipid components of eleven species of Caribbean sharks. Comp Biochem Physiol B (1984) 79:549-54
7. Miller JM, Oligino T, Pazdera M, Lopez AJ, Hoshizaki DK. Identification of fat-cell enhancer regions in Drosophila melanogaster. Insect Mol Biol (2002) 11:67-77. doi:10.1046/j.0962-1075.2001.00310.x
8. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell (2007) 131:242-56. doi:10.1016/j.cell.2007.10.004
9. Item F, Konrad D. Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev (2012) 13(Suppl 2):30-9. doi:10.1111/j.1467-789X.2012.01035.x
10. Smith RE, Horwitz BA. Brown fat and thermogenesis. Physiol Rev (1969) 49:330-425
11. Richard D, Picard F. Brown fat biology and thermogenesis. Front Biosci (Landmark Ed) (2011) 16:1233-60. doi:10.2741/3786
12. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 360:1509-17. doi:10.1056/Nejmoa0810780
13. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. Brief report: functional brown adipose tissue in healthy adults. N Engl J Med (2009) 360:1518-25. doi:10.1056/Nejmoa0808949
14. Friedman JM, Leibel RL, Siegel DS, Walsh J, Bahary N. Molecular mapping of the mouse Ob mutation. Genomics (1991) 11:1054-62. doi:10.1016/0888-7543(91)90032-A
15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 372:425-32. doi:10.1038/372425a0
16. Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine (2006) 29:81-90. doi:10.1385/ENDO
17. Vaisse C, Halaas JL, Horvath CM, Darnell JE, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wildtype and ob/ob mice but not db/db mice. Nat Genet (1996) 14:95-7. doi:10.1038/Ng0996-95
18. Munzberg H, Flier JS, Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology (2004) 145:4880-9. doi:10.1210/en.2004-0726
19. Myers MG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab (2010) 21:643-51. doi:10.1016/j.tem.2010.08.002
20. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene-product on body-weight regulation in Ob/Ob mice. Science (1995) 269:540-3. doi:10.1126/science.7624776
21. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell (1996) 84:491-5. doi:10.1016/S0092-8674(00)81294-5
22. Minokoshi Y, Kim YB, Peroni OD, Fryer LGD, Muller C, Carling D, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature (2002) 415:339-43. doi:10.1038/415339a
23. Guo ZH, Jiang HY, Xu XR, Duan WZ, Mattson MP. Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J Biol Chem (2008) 283:1754-63. doi:10.1074/jbc. M703753200
24. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum-protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 270:26746-9. doi:10.1074/jbc.270.45.26746
25. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem (1996) 271:10697-703. doi:10.1074/jbc.271.18.10697
26. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun (1996) 221:286-9. doi:10.1006/bbrc.1996.0587
27. Berg AH, Combs TP, Du XL, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med (2001) 7:947-53. doi:10.1038/90992
28. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8:731-7. doi:10.1038/nm724
29. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med (2002) 8:1288-95. doi:10.1038/nm788
30. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (vol 423, pg 762-9, 2003). Nature (2004) 431:1123-1123. doi:10.1038/Nature03091
31. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes (2006) 55:2562-70. doi:10.2337/db05-1322
32. Folco EJ, Rocha VZ, Lopez-Ilasaca M, Libby P. Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem (2009) 284:25569-75. doi:10.1074/jbc. M109.019786
33. Lara-Castro C, Luo NL, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes (2006) 55:249-59. doi:10.2337/diabetes.55.01.06.db05-1105
34. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature (2001) 409:307-12. doi:10.1038/35053000
35. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature (2005) 436:356-62. doi:10.1038/nature03711
36. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab (2006) 290:E1253-61. doi:10.1152/ajpendo.00572.2004
37. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes (2007) 56:1655-61. doi:10.2337/db06-1506
38. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology (2010) 151:3169-80. doi:10.1210/en.2009-1358
39. Cao HM, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell (2008) 134:933-44. doi:10.1016/j.cell.2008.07.048
40. Cohen P, Spiegelman BM. Brown and beige fat: molecular parts of a thermogenic machine. Diabetes (2015) 64:2346-51. doi:10.2337/db15-0318
41. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell (1998) 92:829-39. doi:10.1016/S0092-8674(00)81410-5
42. Xue Y, Petrovic N, Cao RH, Larsson O, Lim S, Chen S, et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab (2009) 9:99-109. doi:10.1016/j.cmet.2008.11.009
43. Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med (2013) 19:1252-63. doi:10.1038/nm.3361
44. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature (2008) 454:961-7. doi:10.1038/nature07182
45. Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest (2011) 121:96-105. doi:10.1172/JCI44271
46. Cohen P, Levy JD, Zhang Y, Frontini A, Kolodin DP, Svensson KJ, et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell (2014) 156:304-16. doi:10.1016/j.cell.2013.12.021
47. Himms-Hagen J, Melnyk A, Zingaretti MC, Ceresi E, Barbatelli G, Cinti S. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am J Physiol Cell Physiol (2000) 279:C670-81
48. Schulz TJ, Huang TL, Tran TT, Zhang HB, Townsend KL, Shadrach JL, et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A (2011) 108:143-8. doi:10.1073/pnas.1010929108
49. Vitali A, Murano I, Zingaretti MC, Frontini A, Ricquier D, Cinti S. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J Lipid Res (2012) 53:619-29. doi:10.1194/jlr. M018846
50. Rosenwald M, Perdikari A, Rulicke T, Wolfrum C. Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol (2013) 15:659-67. doi:10.1038/ncb2740
51. Wang QA, Tao C, Gupta RK, Scherer PE. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med (2013) 19:1338-44. doi:10.1038/nm.3324
52. Sharp LZ, Shinoda K, Ohno H, Scheel DW, Tomoda E, Ruiz L, et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One (2012) 7:e49452. doi:10.1371/journal.pone.0049452
53. Jespersen NZ, Larsen TJ, Peijs L, Daugaard S, Homoe P, Loft A, et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab (2013) 17:798-805. doi:10.1016/j.cmet.2013.04.011
54. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell (2012) 150:366-76. doi:10.1016/j.cell.2012.05.016
55. Shinoda K, Luijten IHN, Hasegawa Y, Hong H, Sonne SB, Kim M, et al. Genetic and functional characterization of clonally derived adult human brown adipocytes. Nat Med (2015) 21:389-94. doi:10.1038/nm.3819
56. Chartoumpekis DV, Habeos IG, Ziros PG, Psyrogiannis AI, Kyriazopoulou VE, Papavassiliou AG. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol Med (2011) 17:736-40. doi:10.2119/molmed.2011.00075
57. Hondares E, Iglesias R, Giralt A, Gonzalez FJ, Giralt M, Mampel T, et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem (2011) 286:12983-90. doi:10.1074/jbc. M110.215889
58. Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, et al. FGF21 regulates PGC-1 alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev (2012) 26:271-81. doi:10.1101/gad.177857.111
59. Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, Idelson C, et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab (2014) 19:302-9. doi:10.1016/j.cmet.2013.12.017
60. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature (2008) 454:1000-U1044. doi:10.1038/nature07221
61. Xue RD, Wan Y, Zhang S, Zhang QY, Ye HY, Li YM. Role of bone morphogenetic protein 4 in the differentiation of brown fat-like adipocytes. Am J Physiol Endocrinol Metab (2014) 306:E363-72. doi:10.1152/ajpendo.00119.2013
62. Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol (2014) 10:24-36. doi:10.1038/nrendo.2013.204
63. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell (2001) 104:531-43. doi:10.1016/S0092-8674(01)00240-9
64. Poissonnet CM, Burdi AR, Garn SM. The chronology of adipose tissue appearance and distribution in the human fetus. Early Hum Dev (1984) 10:1-11. doi:10.1016/0378-3782(84)90106-3
65. Knittle JL, Hirsch J. Effect of early nutrition on the development of rat epididymal fat pads: cellularity and metabolism. J Clin Invest (1968) 47:2091-8. doi:10.1172/JCI105894
66. Knittle JL, Timmers K, Ginsberg-Fellner F, Brown RE, Katz DP. The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest (1979) 63:239-46. doi:10.1172/JCI109295
67. Fox K, Peters D, Armstrong N, Sharpe P, Bell M. Abdominal fat deposition in 11-year-old children. Int J Obes Relat Metab Disord (1993) 17:11-6
68. Siegel MJ, Hildebolt CF, Bae KT, Hong C, White NH. Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology (2007) 242:846-56. doi:10.1148/radiol.2423060111
69. Salans LB, Cushman SW, Weismann RE. Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest (1973) 52:929-41. doi:10.1172/JCI107258
70. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev (2000) 21:697-738. doi:10.1210/edrv.21.6.0415
71. Joe AW, Yi L, Even Y, Vogl AW, Rossi FM. Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Stem Cells (2009) 27:2563-70. doi:10.1002/stem.190
72. Hirsch J, Han PW. Cellularity of rat adipose tissue: effects of growth, starvation, and obesity. J Lipid Res (1969) 10:77-82
73. Hirsch J, Knittle JL. Cellularity of obese and nonobese human adipose tissue. Fed Proc (1970) 29:1516-21
74. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, et al. Dynamics of fat cell turnover in humans. Nature (2008) 453:783-7. doi:10.1038/nature06902
75. Salans LB, Knittle JL, Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest (1968) 47:153-65. doi:10.1172/JCI105705
76. Stern JS, Batchelor BR, Hollander N, Cohn CK, Hirsch J. Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet (1972) 2:948-51. doi:10.1016/S0140-6736(72)92474-9
77. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab (2010) 299:E506-15. doi:10.1152/ajpendo.00586.2009
78. Cotillard A, Poitou C, Torcivia A, Bouillot JL, Dietrich A, Kloting N, et al. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab (2014) 99:E1466-70. doi:10.1210/jc.2014-1074
79. Kim JI, Huh JY, Sohn JH, Choe SS, Lee YS, Lim CY, et al. Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation. Mol Cell Biol (2015) 35:1686-99. doi:10.1128/MCB.01321-14
80. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 46:2347-55. doi:10.1194/jlr. M500294-JLR200
81. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW II, DeFuria J, Jick Z, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes (2007) 56:2910-8. doi:10.2337/db07-0767
82. Giordano A, Murano I, Mondini E, Perugini J, Smorlesi A, Severi I, et al. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res (2013) 54:2423-36. doi:10.1194/jlr. M038638
83. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J (2006) 20:1540-2. doi:10.1096/fj.05-5678fje
84. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 293:1673-7. doi:10.1126/science.1061620
85. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature (2002) 420:333-6. doi:10.1038/nature01137
86. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab (2007) 293:E1118-28. doi:10.1152/ajpendo.00435.2007
87. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 29:4467-83. doi:10.1128/MCB.00192-09
88. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev (2013) 93:1-21. doi:10.1152/physrev.00017.2012
89. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes (2007) 56:901-11. doi:10.2337/db06-0911
90. Choe SS, Shin KC, Ka S, Lee YK, Chun JS, Kim JB. Macrophage HIF-2alpha ameliorates adipose tissue inflammation and insulin resistance in obesity. Diabetes (2014) 63:3359-71. doi:10.2337/db13-1965
91. Lee YS, Kim JW, Osborne O, Oh, da Y, Sasik R, et al. Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell (2014) 157:1339-52. doi:10.1016/j.cell.2014.05.012
92. Berger JJ, Barnard RJ. Effect of diet on fat cell size and hormone-sensitive lipase activity. J Appl Physiol (1985) (1999) 87:227-32
93. Wueest S, Rapold RA, Rytka JM, Schoenle EJ, Konrad D. Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice. Diabetologia (2009) 52:541-6. doi:10.1007/s00125-008-1223-5
94. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev (2006) 5:144-64. doi:10.1016/j.arr.2006.03.004
95. Rutkowski JM, Stern JH, Scherer PE. The cell biology of fat expansion. J Cell Biol (2015) 208:501-12. doi:10.1083/jcb.201409063
96. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem (2003) 278:37041-51. doi:10.1074/jbc. M305213200
97. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 116:3015-25. doi:10.1172/JCI28898
98. Song MJ, Kim KH, Yoon JM, Kim JB. Activation of toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun (2006) 346:739-45. doi:10.1016/j.bbrc.2006.05.170
99. Tchkonia T, Tchoukalova YD, Giorgadze N, Pirtskhalava T, Karagiannides I, Forse RA, et al. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2005) 288:E267-77. doi:10.1152/ajpendo.00265.2004
100. Spiegelman BM, Hu E, Kim JB, Brun R. PPAR gamma and the control of adipogenesis. Biochimie (1997) 79:111-2. doi:10.1016/S0300-9084(97)81500-3
101. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell (1999) 3:151-8. doi:10.1016/S1097-2765(00)80306-8
102. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev (2002) 16:22-6. doi:10.1101/gad.948702
103. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev (1996) 10:1096-107. doi:10.1101/gad.10.9.1096
104. Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci U S A (1998) 95:4333-7. doi:10.1073/pnas.95.8.4333
105. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem (1988) 263:9402-8
106. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, et al. Inhibition of adipogenesis by Wnt signaling. Science (2000) 289:950-3. doi:10.1126/science.289.5481.950
107. Huang H, Song TJ, Li X, Hu L, He Q, Liu M, et al. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A (2009) 106:12670-5. doi:10.1073/pnas.0906266106
108. Kim M, Kim JI, Kim JB, Choe S. The activin-betaA/BMP-2 chimera AB204 is a strong stimulator of adipogenesis. J Tissue Eng Regen Med (2015). doi:10.1002/term.2050
109. Sengenes C, Lolmede K, Zakaroff-Girard A, Busse R, Bouloumie A. Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells. J Cell Physiol (2005) 205:114-22. doi:10.1002/jcp.20381
110. Rodeheffer MS, Birsoy K, Friedman JM. Identification of white adipocyte progenitor cells in vivo. Cell (2008) 135:240-9. doi:10.1016/j.cell.2008.09.036
111. Berry R, Rodeheffer MS. Characterization of the adipocyte cellular lineage in vivo. Nat Cell Biol (2013) 15:302-8. doi:10.1038/ncb2696
112. Berry R, Jeffery E, Rodeheffer MS. Weighing in on adipocyte precursors. Cell Metab (2014) 19:8-20. doi:10.1016/j.cmet.2013.10.003
113. Church CD, Berry R, Rodeheffer MS. Isolation and study of adipocyte precursors. Methods Enzymol (2014) 537:31-46. doi:10.1016/B978-0-12-411619-1.00003-3
114. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism (2001) 50:1499-504. doi:10.1053/meta.2001.27213
115. O'Connell J, Lynch L, Cawood TJ, Kwasnik A, Nolan N, Geoghegan J, et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One (2010) 5:e9997. doi:10.1371/journal.pone.0009997
116. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond) (2010) 34(Suppl 2):S18-23. doi:10.1038/ijo.2010.235
117. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) (2011) 35:971-81. doi:10.1038/ijo.2010.216
118. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem (2003) 278:2461-8. doi:10.1074/jbc. M209033200
119. Kusminski CM, Holland WL, Sun K, Park J, Spurgin SB, Lin Y, et al. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med (2012) 18:1539-49. doi:10.1038/nm.2899
120. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem (1995) 270:12953-6. doi:10.1074/jbc.270.22.12953
121. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes (1996) 45:1661-9. doi:10.2337/diabetes.45.12.1661
122. Koh YJ, Park BH, Park JH, Han J, Lee IK, Park JW, et al. Activation of PPAR gamma induces profound multilocularization of adipocytes in adult mouse white adipose tissues. Exp Mol Med (2009) 41:880-95. doi:10.3858/emm.2009.41.12.094
123. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest (2005) 115:1111-9. doi:10.1172/JCI25102
124. Clowes GH Jr, Martin H, Walji S, Hirsch E, Gazitua R, Goodfellow R. Blood insulin responses to blood glucose levels in high output sepsis and spetic shock. Am J Surg (1978) 135:577-83. doi:10.1016/0002-9610(78)90040-5
125. Wichterman KA, Chaudry IH, Baue AE. Studies of peripheral glucose uptake during sepsis. Arch Surg (1979) 114:740-5. doi:10.1001/archsurg.1979.01370300094020
126. Williamson RT. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. Br Med J (1901) 1:760-2. doi:10.1136/bmj.1.2100.760
127. Reid J, Macdougall AI, Andrews MM. Aspirin and diabetes mellitus. Br Med J (1957) 2:1071-4
128. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 259:87-91. doi:10.1126/science.7678183
129. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 29:415-45. doi:10.1146/annurev-immunol-031210-101322
130. Lee YS, Li P, Huh JY, Hwang IJ, Lu M, Kim JI, et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes (2011) 60:2474-83. doi:10.2337/db11-0194
131. Elgazar-Carmon V, Rudich A, Hadad N, Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res (2008) 49:1894-903. doi:10.1194/jlr. M800132-JLR200
132. Talukdar S, Oh, da Y, Bandyopadhyay G, Li D, Xu J, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med (2012) 18:1407-12. doi:10.1038/nm.2885
133. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol (2006) 6:541-50. doi:10.1038/nri1841
134. Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) (2009) 17:2014-8. doi:10.1038/oby.2009.113
135. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 112:1796-808. doi:10.1172/JCI19246
136. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 112:1821-30. doi:10.1172/JCI19451
137. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes (2006) 55:1554-61. doi:10.2337/db06-0133
138. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 116:1494-505. doi:10.1172/JCI26498
139. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2006) 116:115-24. doi:10.1172/JCI24335
140. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 72:219-46. doi:10.1146/annurev-physiol-021909-135846
141. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 8:301-9. doi:10.1016/j.cmet.2008.08.015
142. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res (2008) 103:467-76. doi:10.1161/CIRCRESAHA.108.177105
143. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 15:914-20. doi:10.1038/nm.1964
144. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med (2009) 15:921-9. doi:10.1038/nm.2001
145. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 117:175-84. doi:10.1172/JCI29881
146. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, Jouihan H, Morel CR, Heredia JE, et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci U S A (2010) 107:22617-22. doi:10.1073/pnas.1009152108
147. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science (2011) 332:243-7. doi:10.1126/science.1201475
148. Ji Y, Sun S, Xia S, Yang L, Li X, Qi L. Short-term high-fat-diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem (2012) 287(29):24378-86. doi:10.1074/jbc. M112.371807
149. Ji Y, Sun S, Xu A, Bhargava P, Yang L, Lam KS, et al. Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via the IL-4/STAT6 signaling axis in obesity. J Biol Chem (2012) 287(17):13561-71. doi:10.1074/jbc. M112.350066
150. Lynch L, Nowak M, Varghese B, Clark J, Hogan AE, Toxavidis V, et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity (2012) 37:574-87. doi:10.1016/j.immuni.2012.06.016
151. Schipper HS, Rakhshandehroo M, van de Graaf SF, Venken K, Koppen A, Stienstra R, et al. Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest (2012) 122:3343-54. doi:10.1172/JCI62739
152. Huh JY, Kim JI, Park YJ, Hwang IJ, Lee YS, Sohn JH, et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol (2013) 33:328-39. doi:10.1128/MCB.00552-12
153. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol (2007) 25:297-336. doi:10.1146/annurev.immunol.25.022106.141711
154. Lynch L, Michelet X, Zhang S, Brennan PJ, Moseman A, Lester C, et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat Immunol (2015) 16:85-95. doi:10.1038/ni.3047
155. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 15:930-9. doi:10.1038/nm.2002
156. Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab (2005) 90:2282-9. doi:10.1210/jc.2004-1696
157. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm (2006) 74:443-77. doi:10.1016/S0083-6729(06)74018-3
158. Yu R, Kim CS, Kwon BS, Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity (Silver Spring) (2006) 14:1353-62. doi:10.1038/oby.2006.153
159. Alvehus M, Buren J, Sjostrom M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) (2010) 18:879-83. doi:10.1038/oby.2010.22
160. Bigornia SJ, Farb MG, Mott MM, Hess DT, Carmine B, Fiscale A, et al. Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes (2012) 2:e30. doi:10.1038/nutd.2012.3
161. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism (1987) 36:54-9. doi:10.1016/0026-0495(87)90063-1
162. McLaughlin T, Liu LF, Lamendola C, Shen L, Morton J, Rivas H, et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol (2014) 34:2637-43. doi:10.1161/ATVBAHA.114.304636
163. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes (2009) 58:2574-82. doi:10.2337/db08-1475
164. Anderson EK, Gutierrez DA, Kennedy A, Hasty AH. Weight cycling increases T-cell accumulation in adipose tissue and impairs systemic glucose tolerance. Diabetes (2013) 62:3180-8. doi:10.2337/db12-1076
165. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 447:1116-20. doi:10.1038/nature05894
166. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J (2004) 18:1657-69. doi:10.1096/fj.04-2204com
167. Li P, Lu M, Nguyen MT, Bae EJ, Chapman J, Feng D, et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J Biol Chem (2010) 285:15333-45. doi:10.1074/jbc. M110.100263
168. Mraz M, Lacinova Z, Drapalova J, Haluzikova D, Horinek A, Matoulek M, et al. The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2011) 96:E606-13. doi:10.1210/jc.2010-1858
169. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes (2005) 54:2277-86. doi:10.2337/diabetes.54.8.2277
170. Trachta P, Dostalova I, Haluzikova D, Kasalicky M, Kavalkova P, Drapalova J, et al. Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients. Mol Cell Endocrinol (2014) 383:96-102. doi:10.1016/j.mce.2013.11.013
171. Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H, et al. Bariatric surgery induces disruption in inflammatory signaling pathways mediated by immune cells in adipose tissue: a RNA-Seq study. PLoS One (2015) 10:e0125718. doi:10.1371/journal.pone.0125718
172. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab (2008) 7:496-507. doi:10.1016/j.cmet.2008.04.003
173. Odegaard JI, Chawla A. Alternative macrophage activation and metabolism. Annu Rev Pathol (2011) 6:275-97. doi:10.1146/annurev-pathol-011110-130138
174. Cho CH, Koh YJ, Han J, Sung HK, Jong Lee H, Morisada T, et al. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ Res (2007) 100:e47-57. doi:10.1161/01.RES.0000259564.92792.93
175. Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes (2007) 56:1517-26. doi:10.2337/db06-1749
176. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C, et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation (2008) 117:806-15. doi:10.1161/CIRCULATIONAHA.107.724096
177. Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab (2008) 295:E313-22. doi:10.1152/ajpendo.90296.2008
178. Xu F, Burk D, Gao Z, Yin J, Zhang X, Weng J, et al. Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/-mice. Endocrinology (2012) 153:1706-16. doi:10.1210/en.2011-1667
179. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature (2000) 407:242-8. doi:10.1038/35025215
180. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol (2001) 21:1104-17. doi:10.1161/hq0701.093685
181. Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell (2006) 125:577-91. doi:10.1016/j.cell.2006.02.050
182. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol (2009) 29:1575-91. doi:10.1128/MCB.01300-08
183. Pasarica M, Gowronska-Kozak B, Burk D, Remedios I, Hymel D, Gimble J, et al. Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab (2009) 94:5155-62. doi:10.1210/jc.2009-0947
184. Spencer M, Unal R, Zhu B, Rasouli N, McGehee RE Jr, Peterson CA, et al. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab (2011) 96:E1990-8. doi:10.1210/jc.2011-1567
185. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest (2011) 121:2094-101. doi:10.1172/JCI45887
186. Murdoch C, Muthana M, Lewis CE. Hypoxia regulates macrophage functions in inflammation. J Immunol (2005) 175:6257-63. doi:10.4049/jimmunol.175.10.6257
187. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest (2007) 117:2362-8. doi:10.1172/JCI32239
188. Fan Y, Ye J, Shen F, Zhu Y, Yeghiazarians Y, Zhu W, et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab (2008) 28:90-8. doi:10.1038/sj.jcbfm.9600509
189. Ligresti G, Aplin AC, Zorzi P, Morishita A, Nicosia RF. Macrophage-derived tumor necrosis factor-alpha is an early component of the molecular cascade leading to angiogenesis in response to aortic injury. Arterioscler Thromb Vasc Biol (2011) 31:1151-9. doi:10.1161/ATVBAHA.111.223917
190. Stienstra R, Dijk W, van Beek L, Jansen H, Heemskerk M, Houtkooper RH, et al. Mannose-binding lectin is required for the effective clearance of apoptotic cells by adipose tissue macrophages during obesity. Diabetes (2014) 63:4143-53. doi:10.2337/db14-0256
191. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest (2010) 120:3466-79. doi:10.1172/JCI42845
192. Prieur X, Mok CY, Velagapudi VR, Nunez V, Fuentes L, Montaner D, et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes (2011) 60:797-809. doi:10.2337/db10-0705
193. Shapiro H, Pecht T, Shaco-Levy R, Harman-Boehm I, Kirshtein B, Kuperman Y, et al. Adipose tissue foam cells are present in human obesity. J Clin Endocrinol Metab (2013) 98:1173-81. doi:10.1210/jc.2012-2745
194. Fischer-Posovszky P, Wang QA, Asterholm IW, Rutkowski JM, Scherer PE. Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages. Endocrinology (2011) 152:3074-81. doi:10.1210/en.2011-1031
195. Kato H, Mineda K, Eto H, Doi K, Kuno S, Kinoshita K, et al. Degeneration, regeneration, and cicatrization after fat grafting: dynamic total tissue remodeling during the first 3 months. Plast Reconstr Surg (2014) 133:303e-13e. doi:10.1097/PRS.0000000000000066
196. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature (2011) 480:104-8. doi:10.1038/nature10653
197. Lee YH, Petkova AP, Granneman JG. Identification of an adipogenic niche for adipose tissue remodeling and restoration. Cell Metab (2013) 18:355-67. doi:10.1016/j.cmet.2013.08.003
198. Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM, et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell (2014) 157:1292-308. doi:10.1016/j.cell.2014.03.066